ATE347108T1 - Zusammensetzungen und verfahren zum bestimmen von aa4rp - Google Patents

Zusammensetzungen und verfahren zum bestimmen von aa4rp

Info

Publication number
ATE347108T1
ATE347108T1 AT02781373T AT02781373T ATE347108T1 AT E347108 T1 ATE347108 T1 AT E347108T1 AT 02781373 T AT02781373 T AT 02781373T AT 02781373 T AT02781373 T AT 02781373T AT E347108 T1 ATE347108 T1 AT E347108T1
Authority
AT
Austria
Prior art keywords
aa4rp
compositions
methods
determining
relates
Prior art date
Application number
AT02781373T
Other languages
English (en)
Inventor
Jamila Najib
Zouher Majd
Original Assignee
Genfit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0111598A external-priority patent/FR2829581A1/fr
Priority claimed from FR0210205A external-priority patent/FR2843395A1/fr
Application filed by Genfit filed Critical Genfit
Application granted granted Critical
Publication of ATE347108T1 publication Critical patent/ATE347108T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775—Apolipopeptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT02781373T 2001-09-07 2002-09-06 Zusammensetzungen und verfahren zum bestimmen von aa4rp ATE347108T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0111598A FR2829581A1 (fr) 2001-09-07 2001-09-07 Methodes de criblage de molecules utiles pour la prevention ou le traitement du syndrome metabolique, des maladies cardiovasculaires et de l'atherosclerose
FR0210205A FR2843395A1 (fr) 2002-08-12 2002-08-12 Composition et methodes pour le dosage de l'aa4rp

Publications (1)

Publication Number Publication Date
ATE347108T1 true ATE347108T1 (de) 2006-12-15

Family

ID=26213176

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02781373T ATE347108T1 (de) 2001-09-07 2002-09-06 Zusammensetzungen und verfahren zum bestimmen von aa4rp

Country Status (10)

Country Link
US (1) US20040197823A1 (de)
EP (1) EP1423708B1 (de)
JP (1) JP2005502711A (de)
AT (1) ATE347108T1 (de)
CA (1) CA2459947A1 (de)
DE (1) DE60216482T2 (de)
DK (1) DK1423708T3 (de)
ES (1) ES2275924T3 (de)
IL (1) IL160531A0 (de)
WO (1) WO2003023408A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7972802B2 (en) * 2005-10-31 2011-07-05 University Of Washington Lipoprotein-associated markers for cardiovascular disease
US8241861B1 (en) 2008-07-08 2012-08-14 Insilicos, Llc Methods and compositions for diagnosis or prognosis of cardiovascular disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0976824A1 (de) * 1998-07-10 2000-02-02 Amsterdam Molecular Therapeutics An der Leberregenration beteiligtes Gen und Protein
US6455280B1 (en) * 1998-12-22 2002-09-24 Genset S.A. Methods and compositions for inhibiting neoplastic cell growth
WO2000037491A2 (en) * 1998-12-22 2000-06-29 Genset Dnas encoding proteins with signal sequences
ES2290834T3 (es) * 1999-03-08 2008-02-16 Genentech, Inc. Secuencias de genes amplificados en tumores y sus usos diagnosticos.
AU5559400A (en) * 1999-06-25 2001-01-31 Serono Genetics Institute S.A. Complementary dna's encoding proteins with signal peptides
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins
EP1276754A4 (de) * 2000-04-14 2005-04-06 Nuvelo Inc Materialien und verfahren betreffend den lipidmetabolismus

Also Published As

Publication number Publication date
EP1423708A1 (de) 2004-06-02
WO2003023408A1 (fr) 2003-03-20
US20040197823A1 (en) 2004-10-07
DK1423708T3 (da) 2007-04-02
IL160531A0 (en) 2004-07-25
EP1423708B1 (de) 2006-11-29
JP2005502711A (ja) 2005-01-27
DE60216482D1 (de) 2007-01-11
DE60216482T2 (de) 2007-08-23
CA2459947A1 (fr) 2003-03-20
ES2275924T3 (es) 2007-06-16

Similar Documents

Publication Publication Date Title
EP1379693A4 (de) Auf oligonukleotid-modifizierten partikeln basierende bio-strichcodes
DE69522831T2 (de) Assays und vorrichtungen zum nachweis von extrahepatischer biliäreratresie
ATE540319T1 (de) Verfahren für die bestimmung von fk506
DE69333289D1 (de) Verfahren zur bestimmung von säugetier nukleinsäuren aus stuhlproben und dafür benötigte reagenzien
ATE378404T1 (de) Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
DE60312513D1 (de) Zusammensetzungen und verfahren zum nachweis vom apo-b48 und apo-b100
BG104275A (en) Method and device for express analysis of tested parameters in biological samples
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
ATE408829T1 (de) Verfahren und assaykits zum nachweis mononuklearer zellphänotypen
DE69939121D1 (de) Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
ATE553216T1 (de) Sonden, bibliotheken und kits zur analyse von nukleinsäuregemischen und verfahren zu deren konstruktion
CY1107621T1 (el) Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα
AU3624199A (en) Quantitative method for detecting nucleotide concentration
ATE220112T1 (de) Verfahren zum nachweis von störungen des protein c/protein s-systems
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
ATE416384T1 (de) Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe
DE60310012D1 (de) Verfahren, Assay und Kit zur Quantifizierung von HIV-Proteasehemmer
DE50110174D1 (de) Verfahren und testkit zum nachweis von analyten in einer probe
DE60228952D1 (de) Nachweis von Legionella durch ein PCR und FRET verwendendes Verfahren
DE69942215D1 (de) Verfahren zum immunochemischen Testen des Anti-HM1.24-Antikörpers
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
ATE449868T1 (de) Methoden, testsätze und kompositionen zur detektion und quantifizierung von zielsequenzen
DE602004011228D1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1423708

Country of ref document: EP

REN Ceased due to non-payment of the annual fee